Barry Paul
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 33
- Multiple Myeloma Research and Treatments 32
-
- Protein Degradation and Inhibitors 9
- Cancer-related gene regulation 3
- Epigenetics and DNA Methylation 3
- Co-authors
- Yubin Kang (9 shared papers)Cheryl A. Hobbs (3 shared papers)Susan K. Gilmour (3 shared papers)Saad Z. Usmani (18 shared papers)Daniel Feinberg (5 shared papers)Cesar Rodriguez (1 shared paper)Manisha Bhutani (18 shared papers)Shebli Atrash (22 shared papers)
- Journals
- Blood (12 papers)Cancer Research (3 papers)Cellular Immunology (2 papers)Transplantation and Cellular Therapy (2 papers)Cancer Letters (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Barry Paul
40 papers receiving 403 citations
Peers
Comparison fields: 5 of 60
- Hematology 156
- Oncology 120
- Biochemistry 25
- Molecular Biology 221
- Cancer Research 32
Countries citing papers authored by Barry Paul
This map shows the geographic impact of Barry Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Paul more than expected).
Fields of papers citing papers by Barry Paul
This network shows the impact of papers produced by Barry Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Paul. The network helps show where Barry Paul may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry Paul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors. | 2002 | 48 |
| 2 | 2019 | 44 | |
| 3 | 2020 | 39 | |
| 4 | 2003 | 23 | |
| 5 | 2006 | 22 | |
| 6 | 2020 | 21 | |
| 7 | 2019 | 20 | |
| 8 | 2022 | 20 | |
| 9 | 2019 | 19 | |
| 10 | 2018 | 18 | |
| 11 | 2015 | 15 | |
| 12 | 2021 | 12 | |
| 13 | 2024 | 11 | |
| 14 | 2020 | 10 | |
| 15 | 2022 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2020 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2020 | 6 | |
| 20 | 2020 | 6 |
About Barry Paul
Barry Paul is a scholar working on Hematology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, having authored 44 papers that have together received 410 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (32 papers), Protein Degradation and Inhibitors (9 papers), CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Peptidase Inhibition and Analysis (4 papers), Cancer-related gene regulation (3 papers), Research on Leishmaniasis Studies (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Hematology (156 citations), Oncology (120 citations), Biochemistry (25 citations), Molecular Biology (221 citations) and Cancer Research (32 citations). Barry Paul has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Yubin Kang, Cheryl A. Hobbs, Susan K. Gilmour, Saad Z. Usmani, Daniel Feinberg, Cesar Rodriguez, Manisha Bhutani, Shebli Atrash, Peter M. Voorhees and Enrique M. Ocio. Their work appears in journals such as Blood, Cancer Research, Cellular Immunology, Transplantation and Cellular Therapy and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.